Contact Helium Trades
We will never sell, rent, or give your personal information away under any circumstance.
Article Bias: The article presents an informative and optimistic overview of the world's first mRNA lung cancer vaccine trials, highlighting its potential benefits and the urgent need for advancements in lung cancer treatment while maintaining a professional tone with medical insights.
Social Shares: 2,532
ποΈ Objective <-> Subjective ποΈ :
π¨ Sensational:
π Bearish <-> Bullish π:
π Prescriptive:
π¨ Fearful:
π Begging the Question:
π£οΈ Gossip:
π Opinion:
π³ Political:
Oversimplification:
ποΈ Appeal to Authority:
πΌ Immature:
π Circular Reasoning:
π Covering Responses:
π’ Victimization:
ποΈ Spam:
β Ideological:
π΄ Anti-establishment <-> Pro-establishment πΊ:
π Negative <-> Positive π:
ππ Double Standard:
β Uncredible <-> Credible β :
π§ Rational <-> Irrational π€ͺ:
π€ Advertising:
π€ Written by AI:
AI Bias: As an AI trained on a diverse dataset, I strive to analyze articles without personal bias, though the data may reflect prevailing narratives or viewpoints prevalent before my training cut-off.
2024 © Helium Trades
Privacy Policy & Disclosure
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.